<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Assoc Lab Anim Sci</journal-id><journal-id journal-id-type="iso-abbrev">J. Am. Assoc. Lab. Anim. Sci</journal-id><journal-id journal-id-type="pmc-domain-id">817</journal-id><journal-id journal-id-type="pmc-domain">jaalas</journal-id><journal-id journal-id-type="publisher-id">jaalas</journal-id><journal-title-group><journal-title>Journal of the American Association for Laboratory Animal Science : JAALAS</journal-title></journal-title-group><issn pub-type="ppub">1559-6109</issn><issn pub-type="epub">2769-6677</issn><publisher><publisher-name>American Association for Laboratory Animal Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5605177</article-id><article-id pub-id-type="pmcid-ver">PMC5605177.1</article-id><article-id pub-id-type="pmcaid">5605177</article-id><article-id pub-id-type="pmcaiid">5605177</article-id><article-id pub-id-type="pmid">28903824</article-id><article-id pub-id-type="publisher-id">2017000534</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Anesthesia</subject></subj-group></article-categories><title-group><article-title>Pharmacokinetic Profiles of Nalbuphine after Intraperitoneal and Subcutaneous Administration to C57BL/6 Mice</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Kick</surname><given-names initials="BL">Brenda L</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shu</surname><given-names initials="P">Pan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wen</surname><given-names initials="B">Bo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="D">Duxin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Taylor</surname><given-names initials="DK">Douglas K</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Division of Animal Resources, Emory University, Atlanta, Georgia;</aff><aff id="aff2"><label>2</label>Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Email: <email>bkick@emory.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2017</year></pub-date><pub-date pub-type="epub"><month>9</month><year>2017</year></pub-date><volume>56</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">298611</issue-id><fpage>534</fpage><lpage>538</lpage><history><date date-type="received"><day>21</day><month>3</month><year>2017</year></date><date date-type="rev-recd"><day>11</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>16</day><month>6</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2018</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-08 01:25:58.840"><day>08</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; American Association for Laboratory Animal Science</copyright-statement><copyright-year>2017</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jaalas2017000534.pdf"/><abstract><p>Mice undergo a variety of procedures that necessitate the use of analgesic agents. Opioids are often essential to successful pain management plans, but most are controlled substances, and their use requires appropriate federal and state registrations. Nalbuphine is a potentially effective opioid analgesic for mice that is not currently classified as a controlled substance. This compound has received little attention as an analgesic for mice, and standard dosage regimens have not been developed. Here we compared the pharmacokinetic profiles of 10 mg/kg nalbuphine in male C57BL/6 mice subcutaneous or intraperitoneal administration. Blood was collected from 3 mice per treatment at 5, 10, 20, and 30 min and 1, 2, 3, 6, 12, and 24 h after administration. Plasma concentrations were measured, and standard pharmacokinetic parameters were calculated. Profile characteristics for each route of administration were similar, with significant differences in plasma concentration at 5 and 30 min and 1 and 3 h. Nalbuphine was absorbed more quickly when administered subcutaneously (T<sub>max</sub>, 5 min) than intraperitoneally (T<sub>max</sub>, 10 min), whereas the drug's half-life was similar between the intraperitoneal (0.94 h) and subcutaneous (1.12 h) routes. The AUC<sub>0-tldc</sub> and AUC<sub>0-inf</sub> were higher but the apparent clearance and apparent volume of distribution were lower after subcutaneous administration compared with intraperitoneal dosing. Plasma concentrations were below the level of detection by 12 h. These results suggest that nalbuphine is absorbed in and eliminated quickly from mice, making it a possible candidate for acute pain management.</p></abstract><kwd-group><title>Abbreviations</title><kwd>C<sub>max</sub>, maximal observed concentration</kwd><kwd>SR, sustained release</kwd><kwd>T<sub>max</sub>, time at maximal concentration</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>